RANI

Rani Therapeutics Holdings Inc

Oct 14 • 04:00PM ET

0.4844

+0.0159 3.39 %

Healthcare • Biotechnology • USA • NASD

Peers: REGN BMRN SRPT ASND CRSP FATE NTLA EDIT BLUE LBPH

Index	-	P/E	-	EPS (ttm)	-0.91	Insider Own	24.86%	Shs Outstand	39.24M	Perf Week	-3.06%
Market Cap	34.81M	Forward P/E	-	EPS next Y	-0.41	Insider Trans	0.00%	Shs Float	35.99M	Perf Month	-0.72%
Enterprise Value	42.13M	PEG	-	EPS next Q	-0.11	Inst Own	12.06%	Short Float	0.41%	Perf Quarter	18.15%
Income	-29.69M	P/S	29.01	EPS this Y	48.57%	Inst Trans	2.93%	Short Ratio	0.18	Perf Half Y	-60.62%
Sales	1.20M	P/B	-	EPS next Y	25.00%	ROA	-97.93%	Short Interest	0.15M	Perf YTD	-64.64%
Book/sh	-0.14	P/C	3.25	EPS next 5Y	28.74%	ROE	-1372.59%	52W High	3.75 -87.08%	Perf Year	-79.03%
Cash/sh	0.15	P/FCF	-	EPS past 3/5Y	-35.62% 4.78%	ROIC	-	52W Low	0.39 25.17%	Perf 3Y	-93.19%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-27.67% 0.98%	Gross Margin	15.33%	Volatility	5.69% 5.71%	Perf 5Y	-
Dividend TTM	-	EV/Sales	35.11	EPS Y/Y TTM	22.94%	Oper. Margin	-3796.75%	ATR (14)	0.03	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.54	Sales Y/Y TTM	-	Profit Margin	-2473.83%	RSI (14)	47.00	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	0.54	EPS Q/Q	29.17%	SMA20	-0.99%	Beta	-0.01	Target Price	8.50
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-5.43%	Rel Volume	0.26	Prev Close	0.47
Employees	105	LT Debt/Eq	-	Earnings	Aug 07 AMC	SMA200	-47.15%	Avg Volume	833.82K	Price	0.48
IPO	Jul 30, 2021	Option/Short	Yes / Yes	EPS/Sales Surpr.	36.84% -	Trades		Volume	470,318	Change	3.39%

Date	Action	Analyst	Rating Change	Price Target Change
Aug-02-24	Initiated	Oppenheimer	Outperform	$17
Jun-14-24	Initiated	Maxim Group	Buy	$15
Jun-13-24	Initiated	Rodman & Renshaw	Buy	$10
Apr-17-23	Resumed	BTIG Research	Buy	$24
Oct-11-22	Initiated	UBS	Buy	$15
Jul-27-22	Initiated	H.C. Wainwright	Buy	$22
Jun-13-22	Initiated	Wedbush	Outperform	$28

Aug-07-25 04:05PM	Rani Therapeutics Reports Second Quarter 2025 Financial Results; Provides Corporate Update (GlobeNewswire)
Jul-15-25 09:00AM	Rani Therapeutics Holdings, Inc. Announces Pricing of $3.0 Million Registered Direct Offering (GlobeNewswire) -38.92%
Jul-14-25 05:00AM	Rani Therapeutics and ProGen Announce Late Breaking Presentation at ENDO 2025 Demonstrating Bioequivalence of Novel, Bispecific GLP-1/GLP-2 Receptor Agonist Delivered Orally via RaniPill Compared to Subcutaneous Delivery (GlobeNewswire) +8.45%
May-19-25 08:00AM	Rani Therapeutics Announces Research Agreement with Chugai (GlobeNewswire) +9.27%
May-13-25 04:05PM	Rani Therapeutics Reports First Quarter 2025 Financial Results; Provides Corporate Update (GlobeNewswire) -21.42% +15.59%
10:55AM	Loading…
Apr-01-25 10:55AM	Q4 2024 Rani Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
03:05AM	Rani Therapeutics Holdings Inc (RANI) Q4 2024 Earnings Call Highlights: Navigating Financial ... (GuruFocus.com)
Mar-31-25 07:15PM	Rani Therapeutics Holdings, Inc. (RANI) Q4 2024 Earnings Call Transcript (Seeking Alpha) -7.35%
04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-26-25 04:05PM	Rani Therapeutics Announces Preclinical Data Demonstrating Bioequivalence of RT-114, a GLP-1/GLP-2 Dual Agonist (PG-102) Delivered Orally via the RaniPill Capsule, to Subcutaneously Administered PG-102 (GlobeNewswire) -6.29%
Mar-25-25 06:00PM	Rani Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results (GlobeNewswire)
Feb-05-25 04:05PM	Rani Therapeutics Announces Preclinical Data Demonstrating Successful Oral Delivery of Semaglutide via RaniPill HC (GlobeNewswire) +5.11% +14.58%
Nov-14-24 08:00AM	Rani Therapeutics Reports Third Quarter 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Nov-07-24 04:05PM	Rani Therapeutics to Participate in Upcoming Investor Conferences (GlobeNewswire)
Oct-17-24 08:00AM	Rani Therapeutics Announces New Preclinical Pharmacokinetic Data Supporting Transenteric Delivery of GLP-1 Incretin Triagonist (GlobeNewswire)
08:30AM	Loading…
Oct-15-24 08:30AM	Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering and Cancellation of Certain Existing Warrants (GlobeNewswire) -33.33%
Oct-13-24 06:01AM	Oppenheimer Predicts up to 740% Rally for These 2 Strong Buy Stocks (TipRanks)
Oct-08-24 04:05PM	Rani Therapeutics to Participate in the 2024 Maxim Healthcare Virtual Summit (GlobeNewswire) +7.31%
Sep-03-24 04:05PM	Rani Therapeutics to Participate in September Investor Conferences (GlobeNewswire) -7.50%
Aug-06-24 04:05PM	Rani Therapeutics Reports Second Quarter 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Jul-29-24 04:05PM	Rani Therapeutics to Participate in August Investor Conferences (GlobeNewswire)
Jul-22-24 08:30AM	Rani Therapeutics Holdings, Inc. Announces Pricing of $10.0 Million Registered Direct Offering (GlobeNewswire)
Jun-24-24 07:00AM	Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment (GlobeNewswire)
May-16-24 10:15AM	UBS Adjusts Rani Therapeutics Price Target to $8 From $4, Maintains Buy Rating (MT Newswires)
May-14-24 08:00AM	Rani Therapeutics to Participate in May Investor Conferences (GlobeNewswire) -5.40%
May-09-24 08:00AM	Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill Capsule at Digestive Disease Week 2024 (GlobeNewswire) -5.17%
May-07-24 09:06PM	Rani Therapeutics Q1 2024 Earnings: Financial Performance and Strategic Updates (GuruFocus.com)
May-06-24 09:55PM	RANI Stock Earnings: Rani Therapeutics Hldgs Beats EPS for Q1 2024 (InvestorPlace) +5.73%
04:05PM	Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-21-24 09:45AM	Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2023 Earnings Call Transcript (Insider Monkey)
06:35AM	Loading…
06:35AM	Q4 2023 Rani Therapeutics Holdings Inc Earnings Call (Thomson Reuters StreetEvents)
Mar-20-24 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-15-24 04:05PM	Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results (GlobeNewswire) +6.25%
Feb-05-24 08:00AM	Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) (GlobeNewswire) +5.73%
Dec-14-23 08:00AM	Rani Therapeutics Announces Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1 Incretin Triagonist (GlobeNewswire)
Dec-07-23 12:00PM	What Makes Rani Therapeutics Holdings, Inc. (RANI) a New Buy Stock (Zacks)
Nov-08-23 05:53PM	Rani Therapeutics Holdings Inc (RANI) Reports Q3 2023 Financial Results and Corporate Developments (GuruFocus.com)
04:05PM	Rani Therapeutics Reports Third Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Nov-01-23 04:05PM	Rani Therapeutics Announces Strategic Program Prioritization, Expansion of Manufacturing and Plans to Streamline Business Operations to Support Near-Term Value Drivers and Long-Term Growth of the RaniPill Technology Platform; Reports Preliminary Third Quarter 2023 Financial Results (GlobeNewswire)
Oct-25-23 08:00AM	The RaniPill Capsule, Rani Therapeutics' Oral Delivery Platform, was Well-Tolerated in 60-Day, Repeat-Administration, GLP Safety Study (GlobeNewswire)
Oct-19-23 04:05PM	Rani Therapeutics Announces Successful Oral Delivery of Monoclonal Antibody via High-Capacity Pill in Preclinical Study (GlobeNewswire)
Oct-12-23 04:05PM	Rani Therapeutics to Present Abstract on RT-102 at the 2023 Annual Meeting of the American Society for Bone and Mineral Research (GlobeNewswire)
Sep-18-23 08:00AM	Rani Therapeutics Initiates Phase 1 Study of RT-111 (RaniPill® Containing Ustekinumab Biosimilar, CT-P43) (GlobeNewswire)
Sep-07-23 04:05PM	Rani Therapeutics Announces Successful Drug Delivery of High-Capacity Pill in Preclinical Studies (GlobeNewswire)
Sep-06-23 08:00AM	Rani Therapeutics to Participate in September Investor Conferences (GlobeNewswire)
Aug-11-23 04:05PM	Rani Therapeutics Reports Second Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire)
Aug-04-23 04:05PM	Rani Therapeutics to Participate in August Investor Conferences (GlobeNewswire)
Jun-21-23 08:00AM	Rani Therapeutics Presentation On Oral Delivery of PTH for Osteoporosis Named Presidential Poster Competition Winner at ENDO 2023 Annual Conference (GlobeNewswire)
Jun-08-23 08:00AM	Rani Therapeutics Announces Acceptance of Late-Breaking Abstract of Oral Delivery of GLP-1 Agonist at the American Diabetes Association Annual Conference (GlobeNewswire)
Jun-05-23 08:00AM	Rani Therapeutics and Celltrion Expand Partnership to Include Adalimumab Biosimilar for RT-105 (GlobeNewswire)
Jun-01-23 08:00AM	Rani Therapeutics to Present at the Jefferies Healthcare Conference (GlobeNewswire)
May-31-23 08:00AM	Rani Therapeutics Announces Acceptance of Three Abstracts for Presentation at ENDO 2023 Annual Conference (GlobeNewswire)
May-24-23 08:00AM	Rani Therapeutics Appoints Kate McKinley as Chief Business Officer (GlobeNewswire)
May-17-23 09:50AM	2 Strong Buy Penny Stocks With Over 400% Upside on the Horizon (TipRanks) +12.25%
May-10-23 04:05PM	Rani Therapeutics Reports First Quarter 2023 Financial Results; Provides Corporate Update (GlobeNewswire) -8.84%
Apr-26-23 06:46AM	Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) last week's 14% decline must have disappointed private companies who have a significant stake (Simply Wall St.)
Apr-25-23 08:00AM	Rani Therapeutics to Participate in the H.C. Wainwright BioConnect Investor Conference at NASDAQ (GlobeNewswire)
Apr-11-23 08:00AM	Rani Therapeutics to Present at the 22nd Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-27-23 07:12AM	Rani Therapeutics Holdings, Inc. (NASDAQ:RANI) Q4 2022 Earnings Call Transcript (Insider Monkey)
Mar-22-23 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2022 Financial Results; Provides Corporate Update (GlobeNewswire) -6.89%
Mar-16-23 04:05PM	Rani Therapeutics to Report Fourth Quarter and Full Year 2022 Financial Results and Business Updates (GlobeNewswire) +5.71%
Jan-09-23 08:30AM	Celltrion and Rani Therapeutics Partner on Development of Oral Monoclonal Antibody Treatment (GlobeNewswire)
Jan-05-23 04:05PM	Rani Therapeutics Receives Feedback from Pre-IND Meeting with FDA; Provides Pipeline Update (GlobeNewswire) +8.12%
Dec-06-22 04:05PM	Rani Therapeutics Announces Repeat-Dose Topline Results from RT-102 Phase 1 Study (GlobeNewswire) +9.67%
Nov-17-22 05:30AM	Private companies among Rani Therapeutics Holdings, Inc.'s (NASDAQ:RANI) largest shareholders, saw gain in holdings value after stock jumped 21% last week (Simply Wall St.)
Nov-10-22 05:25PM	Rani Therapeutics Holdings, Inc. (RANI) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
04:05PM	Rani Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update (GlobeNewswire)
Nov-09-22 04:05PM	Rani Therapeutics to Present at the Stifel Healthcare Conference (GlobeNewswire)
Oct-28-22 09:55AM	Here's Why Rani Therapeutics Holdings, Inc. (RANI) Is a Great 'Buy the Bottom' Stock Now (Zacks)
Oct-24-22 08:30AM	Rani Therapeutics Announces New RT-111 Development Program and Provides Corporate Update (GlobeNewswire) -10.03%
Sep-27-22 09:06AM	8 Best Stocks to Buy According to Billionaire Marc Lasry (Insider Monkey)
Sep-06-22 04:05PM	Rani Therapeutics to Present at the H.C. Wainwright 24th Annual Global Investment Conference (GlobeNewswire)
Aug-11-22 11:47PM	Rani Therapeutics Announces Termination of Public Offering of Class A Common Stock (GlobeNewswire) -25.89% +37.55%
Aug-10-22 05:45PM	Rani Therapeutics Holdings, Inc. (RANI) Reports Q2 Loss, Misses Revenue Estimates (Zacks)
05:28PM	Rani Therapeutics Announces Proposed Public Offering of Class A Common Stock (GlobeNewswire)
04:28PM	Rani Therapeutics Reports Second Quarter 2022 Financial Results; Provides Corporate Update (GlobeNewswire)
04:23PM	Rani Therapeutics Announces Positive Topline Results from Phase 1 Study of RT-102 in Osteoporosis (GlobeNewswire)
Aug-08-22 08:30AM	Rani Therapeutics Enters into $45 Million Loan Agreement to Support Ongoing RaniPill® Platform Advancement and Clinical Pipeline Development (GlobeNewswire)
Aug-03-22 07:48AM	Investors in Rani Therapeutics Holdings (NASDAQ:RANI) have made a return of 16% over the past year (Simply Wall St.)
May-11-22 04:05PM	Rani Therapeutics Reports First Quarter 2022 Financial Results; Provides Corporate Update (GlobeNewswire) -5.75%
May-04-22 03:09PM	Companies Like Rani Therapeutics Holdings (NASDAQ:RANI) Are In A Position To Invest In Growth (Simply Wall St.)
May-03-22 04:05PM	Rani Therapeutics to Present at Upcoming Investor Conferences (GlobeNewswire) -6.19%
07:00AM	Rani Therapeutics RaniPill Capsule Named Winner in the Health Category of Fast Companys 2022 World Changing Ideas Awards (GlobeNewswire)
Apr-07-22 04:05PM	Rani Therapeutics to Present at the 21st Annual Needham Virtual Healthcare Conference (GlobeNewswire)
Mar-29-22 04:05PM	Rani Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results; Provides Corporate Update (GlobeNewswire)
Mar-23-22 08:38PM	Rani Therapeutics to Release Fourth Quarter and Full Year 2021 Financial Results on Tuesday, March 29, 2022 (GlobeNewswire)
08:00AM	Rani Therapeutics Announces Initiation of Phase 1 Study of RT-102 Oral PTH for Osteoporosis (GlobeNewswire)
Feb-23-22 08:00AM	Rani Therapeutics Unveils High-Capacity RaniPill Device For Oral Delivery of Biologics; Reports Preliminary 2021 Consolidated Financial Results (GlobeNewswire) -8.47%
Jan-19-22 04:30AM	5 Biotech Stocks That Are Bucking the Selloff (Barrons.com) +7.97%
Jan-07-22 08:00AM	Rani Therapeutics Appoints Lisa Rometty to Board of Directors (GlobeNewswire)
Dec-20-21 07:26PM	These are the top 10 best performing newly public Bay Area stocks (American City Business Journals)
Nov-15-21 07:31PM	Rani Therapeutics Reports Third Quarter 2021 Financial Results, Provides Corporate Update (GlobeNewswire)
Nov-12-21 04:05PM	Rani Therapeutics Appoints Lyn Baranowski to Board of Directors (GlobeNewswire)
Nov-10-21 04:05PM	Rani Therapeutics to Participate in a Fireside Chat at the Stifel 2021 Virtual Healthcare Conference (GlobeNewswire) +6.68%
Oct-08-21 12:42PM	Most of this year's flood of new Bay Area public companies are 'under water' (American City Business Journals) +13.29%
Oct-04-21 06:00AM	This Recent Biologics IPO Could Be Heading Toward a Gain of 60% or More (Motley Fool)
Sep-23-21 04:05PM	Rani Therapeutics to Present at Cantor Fitzgerald Virtual Global Healthcare Conference (GlobeNewswire)
Sep-13-21 04:05PM	Rani Therapeutics Reports Second Quarter 2021 Financial Results, Provides Corporate Update (GlobeNewswire) +6.19% -9.15%
Sep-09-21 08:00AM	Rani Therapeutics Announces Appointment of Eric Groen as General Counsel (GlobeNewswire)
Aug-24-21 02:14PM	Rani Therapeutics, RxSight: 2 Bullish Health Care Stock Picks From BofA (Benzinga)

Rani Therapeutics Holdings, Inc. engages in the operation of a clinical stage bio-therapeutics company. The company was founded by Mir Imran on February 21, 2012 and is headquartered in San Jose, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
McKinley Kate	Chief Business Officer	Dec 13 '24	Buy	1.67	17,960	29,993	17,960	Dec 16 06:00 PM
Imran Talat	Chief Executive Officer	Dec 09 '24	Buy	1.94	10,296	19,974	494,751	Dec 10 01:12 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

RANI

Rani Therapeutics Holdings Inc

Upgrade your FINVIZ experience